GPCR 240816 32.50C (GPCR240816C32500) Stock Options, News & Quotes

US OptionsDetailed Quotes

GPCR240816C32500

Watchlist

3.20
0.000.00%

15min DelayTrading Aug 14 10:54 ET

0.00High0.00Low

Intraday

5D
Daily

News

Cantor Fitzgerald Maintains Structure Therapeutics(GPCR.US) With Buy Rating, Maintains Target Price $65
Moomoo NewsAug 15 08:31 ET · Ratings
Express News | Cantor Fitzgerald Reiterates Overweight on Structure Therapeutics, Maintains $65 Price Target
BenzingaAug 15 08:21 ET
Analysts Offer Insights on Healthcare Companies: Structure Therapeutics, Inc. Sponsored ADR (GPCR) and AbSci (ABSI)
TipRanksAug 15 08:00 ET · Ratings
Buy Rating Affirmed for Structure Therapeutics on Strong Pipeline and Undervalued Patent Portfolio
TipRanksAug 13 09:57 ET · Ratings
Deutsche Bank praises Eli Lilly and Co (LLY.US) as a "high-growth unicorn", with a target price skyrocketing to $1025.
Deutsche Bank has upgraded its rating on Eli Lilly and Co (LLY.US) from "hold" to "buy" with a target price increase from $725 to $1025.
Zhitong FinanceAug 13 02:52 ET
Don't Forget This Startup's Weight-Loss Pill, Analyst Says -- Barrons.com
Barron'sAug 12 16:08 ET · Ratings

Comments

Jensen 108

Aug 13 09:44

$Structure Therapeutics (GPCR.US)$ hopefully the uptrend continues

Meltyy

Jul 17 22:40

Smid-cap obesity stocks hit by $RHHBY positive Ph1 data for oral GLP-1 obesity drug ⚠️

$ROCHE HOLDING AG (RHHBY.US)$
📣 Roche News Snippet:
» CT-996 led to significant weight loss (-7.3%) after 4 weeks 🆚 placebo (-1.2%)
» data supports once-daily oral dosing regimen
» Safety profile was similar to other GLP-1 drugs; no unexpected safety issues observed
Did you see today's sell-off? 🔴
$Eli Lilly and Co (LLY.US)$ $Novo-Nordisk A/S (NVO.US)$ $Structure Therapeutics (GPCR.US)$ $Viking Therapeutics (VKTX.US)$ $Lipocine (LPCN.US)$

frankinglily

Jul 12 03:26

Is the diet pill market too profitable to lose?

Why do you think $Pfizer (PFE.US)$ decided to progress with Danuglipron? (Can't give up this huge market?
The P2 data they published in obese, non-diabetics doesn't look too good. Danuglipron twice daily compared with $Eli Lilly and Co (LLY.US)$ Orforglipron and $Structure Therapeutics (GPCR.US)$ GSBR 1290 at week 12: Orforglipron seems to be the best non-peptide GLP-1 RA

Hashtags

Jun 17 07:49

It seems that they will be going for acquisition of easy to manufacture weight loss pills $Structure Therapeutics (GPCR.US)$

USA faces the most severe drug shortage in a decade, with low stock price drugs and weight loss drugs becoming "disaster zones".

NinjaTradez

Jun 3 21:42

Tradershub.ninja

$Avalon GloboCare (ALBT.US)$ $Affimed NV (AFMD.US)$ $Structure Therapeutics (GPCR.US)$ $Finch Therapeutics (FNCH.US)$
On fire